Trinity UCLA Children Disease Genetic Screening

Over 5,000 human diseases can be classified as monogenic and Mendelian disorders, and these conditions affect millions of people worldwide. Mendelian disorders also significantly contribute to morbidity and mortality of hospital-based pediatric cases. 

Childhood Mendelian disorders account for approximately half of blindness, deafness, severe mental retardation cases, and 40-50% of childhood deaths.

Clinical tests based on whole exome sequencing have been demonstrated to be effective in identifying genetic causes of monogenic and Mendelian diseases. This complex diagnostic process allows the examination of approximately 22,000 genes in the human exome, to improve the yield of diagnosis.

Comply With United States Clinical Regulatory & Patient Privacy Standards
Clinical interpretation provided by the UCLA Clinical Genomics Center and Baylor Genetics follows the current ACMG (American College of Medical Genetics and Genomics) guidelines. The UCLA Clinical Genomics Center and Baylor Genetics also issue physician reports signed-off by their board-certified medical directors.

Free Pharmacogenomic Test of 340+ drugs
The analysis is provided to the physician in the form of static and interactive reports that identifies which prescription drugs are — or aren’t — likely to work. It can predict how a patient’s DNA and current prescriptions may affect their response to medications.

Free consultation of report explanation by Baylor Genetics 

Please note:
- Please read the following Terms and Conditions for more information about the services and preparation for health examination procedures.